Technology
Angle losses widen in 'breakthrough year'
Liquid biopsy specialist Angle described a “breakthrough year” in its 2022 results on Friday, with both FDA clearance and positive results from the ovarian cancer study being achieved.
IQE named 'Gold Tier Supplier' by BAE Systems
Compound semiconductor wafer products and advanced material supplier IQE announced the receipt of a Gold Tier Supplier Award from BAE Systems on Wednesday.
Renalytix reports positive study on clinical value of KidneyIntelX
Biotechnology company Renalytix announced the publication of new case studies in the Diabetic Nephropathy journal on Wednesday, highlighting the clinical value of ‘KidneyIntelX’ in risk stratification for the management of type-2 diabetes and chronic kidney disease (CKD).
Plus500 reports strong first-quarter trading
Multi-asset financial technology company Plus500 reported strong trading in a first-quarter update on Wednesday.
Silverbullet reports solid first quarter revenue growth
Data service provider Silverbullet reported over 100% year-on-year first-quarter revenue growth in an update on Tuesday, with a record £2m of revenue booked.
Futura's erection gel launched over-the-counter in the UK
Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the ‘Eroxon’ brand.
Volex set to beat full-year market expectations
Specialist integrated manufacturer Volex has exceeded market expectations for the 2023 financial year, it reported in an update on Tuesday.
Touchstar to introduce dividend and buyback after strong 2022
Mobile data computing and managed service provider Touchstar reported a 10. 5% increase in total revenue in its final results on Tuesday, to £6. 74m.
Moneysupermarket posts strong first quarter as travel recovers
Moneysupermarket reported a strong first quarter trading performance on Tuesday, underpinned by a recovery in the insurance and travel segments.
N4 Pharma reports progress with siRNA work
N4 Pharma updated the market on its ongoing research work on gene-silencing technology siRNA on Tuesday.
Berenberg stays at 'hold' on BT Group heading into full-year results
Analysts at Berenberg reiterated their 'hold' recommendation and 160. 0p target price on shares of BT Group heading into the company's full-year results on 18 May.
Polarean Imaging appoints director as strategic consultant
Medical imaging technology company Polarean Imaging announced the appointment of non-executive director Daniel Brague as a consultant, with immediate effect.
Avacta presents pre-clinical data for anti-cancer candidate
Life science company Avacta Group announced the presentation of pre-clinical data for its novel ‘preCISION’ proteasome inhibitor AVA3996 on Monday.
Ondine Biomedical reports first-quarter progress
Life sciences company Ondine Biomedical reported a number of operational highlights in a first-quarter update on Monday, including clinical developments for US market approval, additional clinical data and endorsements, and commercial progress.
Cordel losses improve in third quarter
Transport technology specialist Cordel Group reported total third-quarter revenue of £0. 74m in a trading update on Monday - a year-on-year increase of 18%.
Intercede ends year ahead of market forecasts
Cybersecurity software firm Intercede said in a full-year trading update on Monday that its underlying performance had gained further momentum, with full-year revenue expected to have risen at least 21% to around £12m.
Cerillion reports robust first half of trading
Billing, charging, and customer relationship management software specialist Cerillion reported robust first-half trading in an update on Monday, with record-breaking revenue and adjusted EBITDA making for a substantial increase in year-on-year growth.
Tekcapital investee launching ChatGPT-capable smart eyewear
Intellectual property investor Tekcapital announced on Friday that Innovative Eyewear would be holding an eyewear fashion show on 20 April in Miami.
Physiomics to present work at US cancer research summit
Physiomics announced its participation in the American Association for Cancer Research (AACR) annual meeting on Friday, being held in Orlando on 14-19 April.
Revenue rises but earnings slide for Itim Group
Software-as-a-service (SaaS) provider Itim Group reported a 4% increase in group revenue in its 2022 results on Friday to £14m.